M&A NEWS

Astromech buys Form Bio in US$230m all-stock deal

The Church- and Lamm-founded AI biology start-up adds a gene-therapy design platform spun out of Colossal Biosciences.

M&A News deals deskHealthcare / AI drug design · United States, Americas17 Nov 2026

Astromech, a Dallas-based AI company co-founded by geneticist George Church and entrepreneur Ben Lamm, said on 17 November 2026 that it had acquired Form Bio in an all-stock deal valued at US$230m.

Why Astromech is buying Form Bio

Astromech is building a predictive model of biology that combines deep learning on multi-species genomic data with ancestral sequence reconstruction. The deal brings Form Bio's AI-driven platform for designing genetic medicines and gene-therapy constructs under the same roof, and Form Bio's Andrew Busey joins Astromech as chief AI officer and head of technology.

Deal terms and financing

The consideration was paid entirely in Astromech stock. Astromech acquired Form Bio's intellectual property, selected contracts and assets, and its team.

Market context

Form Bio was founded by Ben Lamm, Andrew Busey and Kent Wakeford within Colossal Biosciences, the de-extinction company, and had raised more than US$40m from venture investors.

More United States M&A news

All United States deals →